Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vertex, Inc.

34.48
-1.3600-3.79%
Post-market: 34.480.00000.00%18:57 EDT
Volume:1.18M
Turnover:41.24M
Market Cap:5.46B
PE:-121.62
High:35.93
Open:35.78
Low:34.24
Close:35.84
Loading ...

UBS Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
30 May

3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow

Motley Fool
·
28 May

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
28 May

BMO says Eli Lilly ‘well-priced deal’ to expand presence in pain a positive

TIPRANKS
·
27 May

Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1

StockStory
·
27 May

3 Top Growth Stocks to Buy in the Second Half of 2025

Motley Fool
·
26 May

Vertex Minerals Updates Securities Issue Plan

TIPRANKS
·
26 May

Vertex Minerals Launches Share Purchase Plan Following Successful Placement

TIPRANKS
·
26 May

Vertex Minerals Launches Share Purchase Plan for Shareholders

TIPRANKS
·
26 May

2 Monster Growth Stocks to Buy and Hold for 10 Years

Motley Fool
·
25 May

Argus Adjusts Price Target on Vertex Pharmaceuticals to $525 From $550

MT Newswires Live
·
23 May

Vertex Pharmaceuticals (VRTX) Receives a Hold from Bernstein

TIPRANKS
·
23 May

Vertex Pharmaceuticals downgraded to Hold from Buy at Erste Group

TIPRANKS
·
23 May

Vertex Minerals Updates Share Purchase Plan Timetable

TIPRANKS
·
23 May

Vertex Minerals Appoints New Company Secretary

TIPRANKS
·
23 May

Scotiabank Sticks to Its Hold Rating for Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
21 May

Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030

Motley Fool
·
21 May

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
21 May

CRISPR Therapeutics Stock Could Double Your Money, According to Wall Street. Is It Time to Buy?

Motley Fool
·
20 May

Vertex Minerals Commences Gold Processing at Reward Gold Mine

TIPRANKS
·
20 May